In addition, correlation analysis data showed that significantly altered levels of CXCR3 in different identified T cell subsets, B cell subsets, and myeloid cell subsets dramatically exhibit strong correlations with the clinical diagnostic targets in the T2D-DN subjects (Figure 5). The gene discussed is CXCR3; the disease is type 2 diabetes mellitus.